We spoke to Dr Kazem Rahimi (Oxford University, Oxford, UK) about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and their recent study examining blood pressure lowering to prevent cardiovascular events.
- Could you tell us a little about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and its objectives? (0.13)
- Could you give us an overview of the aims and design of the Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure study? (0.53)
- What were the findings of this study? (1.44)
- What factors should be considered when prescribing blood pressure-lowering medication? (2.32)
- What future studies are planned? (3.48)
Speaker disclosures: Dr Kazem Rahimi has received funding from British Heart Foundation, NIHR Biomedical Research Centre and Oxford Martin School, University of Oxford.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Dr Kazem Rahimi, September 2020.
Share this Video
Related Videos In Cardiovascular Disease
Wolfgang Linke, ESC 2021 – Key Pathomechanisms of TTNtv-dilated Cardiomyopathy
Dr Wolfgang Linke (Professor and Chair of Physiology, University Hospital of Münster, Münster, Germany) kindly shared his thoughts on the titin gene TTNtv and dilated cardiomyopathy from the virtual ESC Congress 2021. Questions What is known about the correlation between variants in the titin gene (TTNtv) and the incidence of dilated cardiomyopathy (DCM), and what […]
Stephen Nicholls, ESC 2021 – the HUYGENS Study
Prof. Stephen Nicholls (Professor of Cardiology, Monash University, Melbourne, Australia) kindly shared his thoughts on the impact of PCSK9 inhibitors on lipid-lowering therapy, the effects of statins on coronary atherosclerotic plaques and the HUYGENS study from the virtual ESC Congress 2021. Questions What has been the impact of PCSK9 inhibitors on lipid-lowering therapy, and what […]
Jordan Strom, ESC 2021 – Analysis of the Risks of Moderate and Lesser Aortic Stenosis
Dr Jordan Strom (Director of Echocardiographic Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) kindly shared his thoughts on his recent analysis of clinical trial and administrative claims data on patients with untreated aortic stenosis from the virtual ESC Congress 2021. Questions What are the aims and scope of your current […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!